Human TACI/TNFRSF13B Protein, Accession: O14836

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Human TACI/TNFRSF13B Protein is expressed from HEK293 with hFc tag at the C-terminal.It contains Ser2-Thr166.

    Biotinylated

    产物规格

    靶点

    TACI/TNFRSF13B

    份子又名

    CD267; TNFRSF13B; TACI; CVID; CVID2; IGAD2; RYZN; TACI

    Accession

    种属

    Human

    卵白序列

    Ser2-Thr166

    份子量

    The protein has a predicted MW of 45.3 kDa. Due to glycosylation, the protein migrates to 38-40 kDa and 50-55 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Human BAFF Trimer, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human TACI, hFc Tag with the EC50 of 3.0ng/ml determined by ELISA. See testing image for detail.

    产物标签

    C-hFc

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Liquid

    运输前提

    Shipped with blue ice.

    制剂

    Supplied as 0.22um filtered solution in PBS (pH 7.4).

    复溶

    存储和不变性

    Valid for 12 months from date of receipt when stored at -80°C.； Recommend to aliquot the protein into smaller quantities for optimal storage. Please avoid repeated freeze-thaw cycles. 该终产物的该品牌ChemWhat是Watson的注册成功品种，由Watson受权浙江海角社区 在国台湾地区温带季风气候凭借，点此拜候。